Search
Search Results
-
Androgenetic Alopecia: Therapy Update
Androgenetic alopecia (AGA), also known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL), is the most common form of alopecia...
-
Comorbidities in Androgenetic Alopecia: A Comprehensive Review
Androgenetic alopecia is the most common form of hair loss, affecting 85% of men and 40% of women. Androgenetic alopecia is a disease caused by...
-
Meta-Analysis of Efficacy of Platelet-Rich Plasma Combined with Minoxidil for Androgenetic Alopecia
BackgroundAndrogenetic alopecia (AGA) is a prevalent type of hair loss that impacts individuals of both genders. Platelet-rich plasma (PRP) and...
-
What’s New in Therapy for Male Androgenetic Alopecia?
Male androgenetic alopecia is a common condition and represents a major concern for patients who experience this condition. While there are different...
-
Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment
IntroductionAndrogenetic alopecia (AGA) is a prevalent, multifactorial form of hair loss involving complex aetiological factors, such as altered...
-
Oral minoxidil use in androgenetic alopecia and telogen effluvium
While current studies have supported oral minoxidil as a novel, adjunctive therapy in non-scarring forms of alopecia, there continues to be limited...
-
Intradermal Injection in Balding Region Versus Intramuscular Injection in Surrounding Muscles: A Split-Scalp, Randomized Trial on BoNT for Androgenetic Alopecia
IntroductionRecent advancements in androgenetic alopecia (AGA) treatment have highlighted the efficacy of botulinum toxin (BoNT). However,...
-
PRECISE Scale: a quantitative classification for androgenetic alopecia and its application to hair transplantation
BackgroundAndrogenetic alopecia (AGA) is a prevalent genetic condition that can affect both male and female, and is considered the most frequent form...
-
Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis
Androgenetic alopecia is a widespread condition that is the most common type of hair loss affecting approximately 58% and 40% of men and women by the...
-
Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia
Laser sources have established their potential effect in inducing hair regrowth. No large cohort study has evaluated the effect of ablative...
-
Use of fractionated laser therapy for the treatment of androgenetic alopecia: a systematic review and meta-analysis
Procedural management, including fractionated laser therapy, has been increasingly investigated for the management of androgenetic alopecia (AGA)....
-
Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia
IntroductionThis study assessed the levels of compliance to topical minoxidil (TM) among male and female patients with androgenetic alopecia (AGA)...
-
Sleep quality in men with androgenetic alopecia
PurposeSleep disturbances affect human health and contribute to several comorbidities. In men, androgenetic alopecia (AGA) is a common, non-scarring...
-
Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients
BackgroundAndrogenetic alopecia (AGA), one of the most common types of hair loss, is associated with oxidative stress, inflammation and aging....
-
-
-
Botulinum Toxin Type A Alleviates Androgenetic Alopecia by Inhibiting Apoptosis of Dermal Papilla Cells via Targeting circ_0135062/miR-506-3p/Bax Axis
Botulinum toxin type A (BTXA) has the potential to treat androgenetic alopecia (AGA); however, its impact on the apoptosis of dermal papillary cells...
-
Health Utility Measures Among Patients with Androgenetic Alopecia After Hair Transplant
BackgroundHair loss causes significant psychosocial distress to patients. Health utility measurements offer an objective, quantitative assessment of...
-
Evaluation of dry eye and Meibomian gland dysfunction in female androgenetic alopecia patients
PurposeTo evaluate dry eye tests and Meibomian gland functions in female androgenetic alopecia patients.
Materials and methodsTwenty left eyes of 20...